SAN ANTONIO — The Cancer Prevention and Research Institute of Texas has awarded nearly $3.4 million to UT Health San Antonio to advance research ...
News
- UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts
- bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA ...
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics ...
- bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics and ...
- bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA ...
SAN ANTONIO--(BUSINESS WIRE)--Jun 26, 2025--. bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer ...
- Eye-focused biotech Perfuse Therapeutics zeroes in on pivotal studies to restore vision
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Dr. Sevgi Gurkan is a sort of plumber for the eye, and now the lead ...